课题基金 / 基金详情

Broad Institute Center for Cancer Systems Biology

Broad Institute Center for Cancer Systems Biology
布罗德癌症系统生物学中心
批准号:
8444659
负责人:
TODD R. GOLUB
金额:
$200.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-03-01 至 2015-02-28

项目摘要

项目成果

TODD R. GOLUB的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed Broad Institute Center for Cancer Systems Biology represents a multi-investigator effort that has several concrete goals. First, we aim to create and maintain a vibrant community of cancer biologists and computational scientists devoted to exploring the emerging field of cancer systems biology. This will involve maintaining a rich intellectual environment that rigorously develops new, and highly integrated experimental and computational approaches to cancer research. This will involve training a next generation of cancer researchers who become increasingly expert at this cancer biology / computational biology interface, through the development and dissemination of computational tools (software), cross-disciplinary training, and multimedia educational materials. In addition, the Center will take on an ambitious, multiinvestigator research project aimed at identifying the essential genes (Achilles' Heels) of cancers of different types, and developing advanced computational models that use the molecular features of cancer cells to predict these essentialities. If successful, this effort would yield both new insights into the molecular circuitry of cancer cells, and would also provide a new path towards personalized cancer medicine, whereby the molecular features of a patient's tumor are predictive of their response to specific therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovering existing medicines that abrogate cellular responses to SARS CoV-2 infection
  • 批准号:
    10199270
  • 项目类别:
  • 资助金额:
    $165.28万
  • 财政年份:
    2020
  • 负责人:
    TODD R. GOLUB
  • 依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
  • 批准号:
    10018814
  • 项目类别:
  • 资助金额:
    $102.43万
  • 财政年份:
    2019
  • 负责人:
    TODD R. GOLUB
  • 依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
  • 批准号:
    10473781
  • 项目类别:
  • 资助金额:
    $100.38万
  • 财政年份:
    2019
  • 负责人:
    TODD R. GOLUB
  • 依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
  • 批准号:
    9816920
  • 项目类别:
  • 资助金额:
    $102.43万
  • 财政年份:
    2019
  • 负责人:
    TODD R. GOLUB
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: